Literature DB >> 10878485

Determination and Successful Transfusion of Anti-Gerbich-Positive Red Blood Cells in a Patient with a Strongly Reactive Anti-Gerbich Antibody.

.   

Abstract

Background: The clinical relevance of antibodies directed against members of the Gerbich (GE) family of antigens is not invariably clear. Given the scarcity of serologically compatible red blood cells (RBC), various methods may have to be applied to assess the safety of transfusing serologically incompatible RBC. Patient and
Methods: The serum of a 57-year-old male Caucasian admitted to hospital for gastrectomy was found to contain a highly reactive anti-GE2 antibody (IgG(1)). In addition to a monocyte monolayer assay, 50 ml of GE2-positive RBC were transfused, and blood samples were taken before and 1 and 24 h after transfusion for flow-cytometric determination of transfused cells.
Results: Both tests showed no increased destruction of GE2-positive RBC. The transfusion of 4 units of GE2-positive RBC was well tolerated, and hemoglobin increased adequately.
Conclusion: This case may extend the information available not only on antibodies directed against members of the GE family of antigens but also on methods to estimate the survival of transfused RBC. Copyright 2000 S. Karger GmbH, Freiburg

Entities:  

Year:  2000        PMID: 10878485     DOI: 10.1159/000025261

Source DB:  PubMed          Journal:  Infusionsther Transfusionsmed        ISSN: 1019-8466


  3 in total

1.  The first Korean case report of anti-Gerbich.

Authors:  You La Jeon; Tae Sung Park; Sun Young Cho; Seung Hwan Oh; Myeong Hee Kim; So Young Kang; Woo-In Lee
Journal:  Ann Lab Med       Date:  2012-10-17       Impact factor: 3.464

2.  Central hepatectomy for hepatocellular carcinoma in a patient with anti-Gerbich antibody.

Authors:  Teruo Komokata; Maki Inoue; Bibek Aryal; Hiroto Yasumura; Chinami Mori; Mituharu Nomoto; Mamoru Kaieda; Shuichi Hanada
Journal:  Surg Case Rep       Date:  2020-06-12

3.  Identification of Anti-Gerbich Antibody in an Emirati Marrow Hematopoietic Progenitor Cell Donor with Fy(a-b-) Phenotype.

Authors:  Seung Jun Choi; Eunkyung Lee; Sinyoung Kim; Chuhl Joo Lyu; Hyun Ok Kim
Journal:  Yonsei Med J       Date:  2018-12       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.